Docusign Envelope ID: F9E44E73-CEF3-47C7-A82E-D62F3AE837A6
Charity number: 1141310
CURE CANCER @ UCL CANCER INSTITUTE
UNAUDITED
TRUSTEES' REPORT AND FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2024
Docusign Envelope ID: F9E44E73-CEF3-47C7-A82E-D62F3AE837A6
CURE CANCER @ UCL CANCER INSTITUTE
CONTENTS
| Page | |
|---|---|
| Reference and administrative details of the charity, its trustees and advisers | 1 |
| Trustees' report | 2 - 3 |
| Independent examiner's report | 4 |
| Statement of financial activities | 5 |
| Balance sheet | 6 |
| Notes to the financial statements | 7 - 14 |
Docusign Envelope ID: F9E44E73-CEF3-47C7-A82E-D62F3AE837A6
CURE CANCER @ UCL CANCER INSTITUTE
REFERENCE AND ADMINISTRATIVE DETAILS OF THE CHARITY, ITS TRUSTEES AND ADVISERS FOR THE YEAR ENDED 31 MARCH 2024
Trustees
Siamack Bagheri (appointed 28 November 2024) Sandra Hamilton Natasha Hamilton Julian Margolin Stephen Sampson
Charity registered number
1141310
Principal office
Pitt House 120 Baker Street London W1U 6TU
Accountants
Griffin Stone Moscrop & Co Chartered Accountants 21-27 Lamb's Conduit Street London WC1N 3GS
Bankers
Natwest Bank Plc 9 The Broadway Stanmore Middx HA7 4DA
Page 1
Docusign Envelope ID: F9E44E73-CEF3-47C7-A82E-D62F3AE837A6
CURE CANCER @ UCL CANCER INSTITUTE
TRUSTEES' REPORT FOR THE YEAR ENDED 31 MARCH 2024
The trustees present their annual report together with the financial statements of the charity for the period 1 April 2023 to 31 March 2024.
The charity also operates under the name Cure Cancer @ UCL.
Objectives and activities
Policies and objectives
The principal object of the charity is to relieve sickness and to promote and protect good health for the public benefit by funding research and equipment to assist with this research at University College London (UCL) and other institutions into lymphomas, other and related diseases.
In particular, the charity raises funds to enable it to purchase capital equipment and consumable supplies on behalf of the UCL Cancer Institute.
Achievements and performance
Review of activities
The charity continued to raise funds during the year under review in holding a variety of events. Expenditure on equipment purchases is influenced by the requests that the charity receives from the research team that it primarily supports.
Public benefit
The trustees have had due regard to guidance published by the Charity Commission on public benefit. All of the charity's activities have been planned and undertaken in order to raise funds for the relief of sickness and to promote and protect good health, thus ensuring that the charity meets the Charity Commission's public benefit criteria.
Financial review
Results
Total income for the year amounted to £26,830, and the net movement in funds totalled £20,248. The charity had net funds of £88,349 at 31 March 2024, all of which were unrestricted. The trustees consider the overall state of affairs of the charity to be satisfactory.
Principal risks and uncertainties
By striving to minimise its running costs and with the ability to increase or decrease its charitable activities depending upon the level of incoming resources, the trustees consider that the impact of risk and uncertainty on the charity has, as far as possible, been mitigated.
Reserves policy
The charity's activities are such that, in the opinion of the trustees, a formal reserves policy is unnecessary.
Structure, governance and management
Constitution
The charity's governing document is its Trust Deed dated 7 April 2011 and amended on 27 October 2011.
Page 2
Docusign Envelope ID: F9E44E73-CEF3-47C7-A82E-D62F3AE837A6
CURE CANCER @ UCL CANCER INSTITUTE
TRUSTEES' REPORT (CONTINUED) FOR THE YEAR ENDED 31 MARCH 2024
Method of appointment or election of trustees
The management of the charity is the responsibility of the trustees who are elected and co-opted under the terms of the Trust Deed.
Trustees' responsibilities statement
The trustees are responsible for preparing the trustees' report and the financial statements in accordance with applicable law and United Kingdom Accounting Standards (United Kingdom Generally Accepted Accounting Practice).
The law applicable to charities in England & Wales requires the trustees to prepare financial statements for each financial year which give a true and fair view of the state of affairs of the charity and of the incoming resources and application of resources of the charity for that period. In preparing these financial statements, the trustees are required to:
-
select suitable accounting policies and then apply them consistently;
-
observe the methods and principles in the Charities SORP;
-
make judgements and accounting estimates that are reasonable and prudent;
-
prepare the financial statements on the going concern basis unless it is inappropriate to presume that the charity will continue in operation.
The trustees are responsible for keeping proper accounting records that are sufficient to show and explain the charity's transactions and disclose with reasonable accuracy at any time the financial position of the charity and enable them to ensure that the financial statements comply with the Charities Act 2011, the Charity (Accounts and Reports) Regulations 2008 and the provisions of the trust deed. They are also responsible for safeguarding the assets of the charity and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities.
Approved by order of the members of the board of trustees and signed on their behalf by:
................................................
Stephen Sampson Trustee 20/1/2025 Date:
Page 3
Docusign Envelope ID: F9E44E73-CEF3-47C7-A82E-D62F3AE837A6
CURE CANCER @ UCL CANCER INSTITUTE
INDEPENDENT EXAMINER'S REPORT FOR THE YEAR ENDED 31 MARCH 2024
Independent examiner's report to the trustees of Cure Cancer @ UCL Cancer Institute ('the charity')
I report to the charity trustees on my examination of the financial statements of the charity for the year ended 31 March 2024.
Responsibilities and basis of report
As the trustees of the charity you are responsible for the preparation of the accounts in accordance with the requirements of the Charities Act 2011 ('the 2011 Act').
I report in respect of my examination of the charity's accounts carried out under section 145 of the 2011 Act and in carrying out my examination I have followed the applicable Directions given by the Charity Commission under section 145(5)(b) of the 2011 Act.
Independent examiner's statement
Your attention is drawn to the fact that the charity has prepared the accounts in accordance with Accounting and Reporting by Charities: Statement of Recommended Practice applicable to charities preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102) in preference to the Accounting and Reporting by Charities: Statement of Recommended Practice issued on 1 April 2005 which is referred to in the extant regulations but has been withdrawn.
I understand that this has been done in order for the accounts to provide a true and fair view in accordance with the Generally Accepted Accounting Practice effective for reporting periods beginning on or after 1 January 2015.
I have completed my examination. I confirm that no matters have come to my attention in connection with the examination giving me cause to believe that in any material respect:
-
accounting records were not kept in respect of the charity as required by section 130 of the 2011 Act; or
-
the accounts do not accord with those records; or
-
the accounts do not comply with the applicable requirements concerning the form and content of accounts set out in the Charities (Accounts and Reports) Regulations 2008 other than any requirement that the accounts give a 'true and fair' view which is not a matter considered as part of an independent examination.
I have no concerns and have come across no other matters in connection with the examination to which attention should be drawn in this report in order to enable a proper understanding of the accounts to be reached.
This report is made solely to the charity's trustees, as a body, in accordance with Part 4 of the Charities (Accounts and Reports) Regulations 2008. My work has been undertaken so that I might state to the charity's trustees those matters I am required to state to them in an independent examiner's report and for no other purpose. To the fullest extent permitted by law, I do not accept or assume responsibility to anyone other than the charity and the charity's trustees as a body, for my work or for this report.
Signed: Dated: 20/1/2025 Richard Hill FCA
Griffin Stone Moscrop & Co Chartered Accountants 21-27 Lamb's Conduit Street London WC1N 3GS
Page 4
Docusign Envelope ID: F9E44E73-CEF3-47C7-A82E-D62F3AE837A6
CURE CANCER @ UCL CANCER INSTITUTE
STATEMENT OF FINANCIAL ACTIVITIES FOR THE YEAR ENDED 31 MARCH 2024
| Note Income from: Donations and grants 3 Charitable activities 4 Investments 5 Total income Expenditure on: Charitable activities 6 Total expenditure Net income Net movement in funds Reconciliation of funds: Total funds brought forward Total funds carried forward |
Restricted funds 2024 £ - 1,000 - 1,000 1,000 1,000 - - - - |
Unrestricted fund 2024 £ 7,160 17,426 1,244 25,830 5,582 5,582 20,248 20,248 68,101 88,349 |
Total funds 2024 £ 7,160 18,426 1,244 26,830 6,582 6,582 20,248 20,248 68,101 88,349 |
Total funds 2023 £ 18,571 32,237 133 |
|---|---|---|---|---|
| 50,941 | ||||
| 8,405 | ||||
| 8,405 | ||||
| 42,536 | ||||
| 42,536 | ||||
| 25,565 | ||||
| 68,101 |
The statement of financial activities includes all gains and losses recognised in the year.
The notes on pages 7 to 14 form part of these financial statements.
Page 5
Docusign Envelope ID: F9E44E73-CEF3-47C7-A82E-D62F3AE837A6
CURE CANCER @ UCL CANCER INSTITUTE
BALANCE SHEET AS AT 31 MARCH 2024
| Note Current assets Debtors 9 Cash at bank Creditors: amounts falling due within one year 10 Net current assets Total net assets Charity funds Unrestricted fund 12 Total funds |
2,290 87,519 89,809 (1,460) |
2024 £ 88,349 88,349 88,349 88,349 |
3,142 65,841 68,983 (882) |
2023 £ 68,101 |
|---|---|---|---|---|
| 68,101 | ||||
| 68,101 | ||||
| 68,101 |
The financial statements were approved and authorised for issue by the trustees and signed on their behalf by:
................................................
Stephen Sampson Trustee Date: 20/1/2025
The notes on pages 7 to 14 form part of these financial statements.
Page 6
Docusign Envelope ID: F9E44E73-CEF3-47C7-A82E-D62F3AE837A6
CURE CANCER @ UCL CANCER INSTITUTE
NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 MARCH 2024
1. General information
Cure Cancer @ UCL Cancer Institute is a charity registered in England, registration number 1141310. Its principal office is Pitt House, 120 Baker Street, London, W1U 6TU.
2. Accounting policies
2.1 Basis of preparation of financial statements
The financial statements have been prepared in accordance with the Charities SORP (FRS 102) - Statement of Recommended Practice: Accounting and Reporting by Charities preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102) issued in October 2019, the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102) and the Charities Act 2011.
The financial statements have been prepared to give a 'true and fair' view and have departed from the Charities (Accounts and Reports) Regulations 2008 only to the extent required to provide a 'true and fair' view. This departure has involved following the Charities SORP (FRS 102) (effective 1 January 2019) rather than the Accounting and Reporting by Charities: Statement of Recommended Practice effective from 1 April 2005 which has since been withdrawn.
The financial statements are prepared in sterling, which is the functional currency of the charity, and are rounded to the nearest £1.
The preparation of financial statements in compliance with the Charities SORP (FRS 102) and FRS 102 requires the use of certain critical accounting estimates. It also requires management to exercise judgement in applying the charity's accounting policies (see note 14).
Assets and liabilities are initially recognised at historical cost or transaction value unless otherwise stated in the relevant accounting policy.
Cure Cancer @ UCL Cancer Institute meets the definition of a public benefit entity under FRS 102.
2.2 Fund accounting
General funds are unrestricted funds which are available for use at the discretion of the trustees in furtherance of the general objectives of the charity and which have not been designated for other purposes.
2.3 Income
All income is recognised once the charity has entitlement to the income, it is probable that the income will be received and the amount of income receivable can be measured reliably.
Income tax recoverable in relation to donations received under Gift Aid or deeds of covenant is recognised at the time of the donation.
Page 7
Docusign Envelope ID: F9E44E73-CEF3-47C7-A82E-D62F3AE837A6
CURE CANCER @ UCL CANCER INSTITUTE
NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 MARCH 2024
2. Accounting policies (continued)
2.4 Expenditure
Expenditure is recognised once there is a legal or constructive obligation to transfer economic benefit to a third party, it is probable that a transfer of economic benefits will be required in settlement and the amount of the obligation can be measured reliably.
All expenditure is accounted for on an accruals basis. All expenses including support costs and governance costs are allocated to the applicable expenditure headings.
Support costs are those costs incurred directly in support of expenditure on the objects of the charity and include the costs of staging events to publicise the work and profile of the charity with a view to increasing the amount of money that the charity can raise. Governance costs are those incurred in connection with administration of the charity and compliance with constitutional and statutory requirements.
Irrecoverable VAT is charged against the expenditure heading for which it was incurred.
Expenditure on charitable activities is incurred on directly undertaking the activities which further the charity's objectives, as well as any associated support costs.
Grants payable are charged in the year when the offer is made except in those cases where the offer is conditional, such grants being recognised as expenditure when the conditions attaching are fulfilled. Grants offered subject to conditions which have not been met at the year end are noted as a commitment, but not accrued as expenditure.
2.5 Interest receivable
Interest on funds held on deposit is included when receivable and the amount can be measured reliably by the charity; this is normally upon notification of the interest paid or payable by the bank.
2.6 Debtors
Trade and other debtors are recognised at the settlement amount after any trade discount offered. Prepayments are valued at the amount prepaid net of any trade discounts due.
2.7 Cash at bank
Cash at bank includes short-term highly liquid investments with a short maturity of three months or less from the date of acquisition or opening of the deposit or similar account.
2.8 Liabilities and provisions
Liabilities are recognised when there is an obligation at the balance sheet date as a result of a past event, it is probable that a transfer of economic benefit will be required in settlement, and the amount of the settlement can be estimated reliably.
Liabilities are recognised at the amount that the charity anticipates it will pay to settle the debt or the amount it has received as advanced payments for the goods or services it must provide.
Provisions are measured at the best estimate of the amounts required to settle the obligation. Where the effect of the time value of money is material, the provision is based on the present value of those amounts, discounted at the pre-tax discount rate that reflects the risks specific to the liability. The unwinding of the discount is recognised in the statement of financial activities as a finance cost.
Page 8
Docusign Envelope ID: F9E44E73-CEF3-47C7-A82E-D62F3AE837A6
CURE CANCER @ UCL CANCER INSTITUTE
NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 MARCH 2024
2. Accounting policies (continued)
2.9 Financial instruments
The charity only has financial assets and financial liabilities of a kind that qualify as basic financial instruments. Basic financial instruments are initially recognised at transaction value and subsequently measured at their settlement value with the exception of bank loans which are subsequently measured at amortised cost using the effective interest method.
2.10 Going concern
There are no material uncertainties relating to the charity's ability to continue as a going concern.
3. Income from donations and grants
| Unrestricted fund 2024 £ Donations 6,914 Grants 246 Total 2024 7,160 Total 2023 18,571 |
Total funds 2024 £ 6,914 246 7,160 18,571 |
Total funds 2023 £ 18,571 - |
|---|---|---|
| 18,571 | ||
4. Income from charitable activities
| Ticket sales Sponsorship income Other income Total 2024 Total 2023 |
Restricted funds 2024 Unrestricted fund 2024 £ £ - 16,705 - - 1,000 721 1,000 17,426 - 32,237 |
Total funds 2024 £ 16,705 - 1,721 18,426 32,237 |
Total funds 2023 £ 26,364 3,844 2,029 |
|---|---|---|---|
| 32,237 | |||
Page 9
Docusign Envelope ID: F9E44E73-CEF3-47C7-A82E-D62F3AE837A6
CURE CANCER @ UCL CANCER INSTITUTE
NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 MARCH 2024
5. Income from investments
| Unrestricted fund 2024 £ Bank interest receivable 1,244 Total 2023 133 |
Total funds 2024 £ 1,244 133 |
Total funds 2023 £ 133 |
|---|---|---|
6. Analysis of expenditure on charitable activities
Summary by fund type
| Support of UCL Cancer Institute Total 2023 |
Restricted funds 2024 Unrestricted fund 2024 £ £ 1,000 5,582 - 8,405 |
Total 2024 £ 6,582 8,405 |
Total 2023 £ 8,405 |
|---|---|---|---|
The charity has no employees and its only key management personnel are the trustees (2023 - the same).
7. Analysis of expenditure by activities
| Direct | Support | Total | Total | |
|---|---|---|---|---|
| costs | costs | funds | funds | |
| 2024 | 2024 | 2024 | 2023 | |
| £ | £ | £ | £ | |
| Support of UCL Cancer Institute | - | 6,582 | 6,582 | 8,405 |
Page 10
Docusign Envelope ID: F9E44E73-CEF3-47C7-A82E-D62F3AE837A6
CURE CANCER @ UCL CANCER INSTITUTE
NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 MARCH 2024
7. Analysis of expenditure by activities (continued)
Analysis of direct costs
| Costs of masks and sanitizer Equipment purchased for UCL Cancer Institute Total 2024 |
Total funds 2024 £ - - - |
Total funds 2023 £ 397 5,245 |
|---|---|---|
| 5,642 |
Analysis of support costs
| Venue hire Event production costs General expenses Stationery Independent examination Total 2024 |
Total funds 2024 £ 3,000 2,476 28 76 1,002 6,582 |
Total funds 2023 £ 1,189 650 - - 924 |
|---|---|---|
| 2,763 |
8. Trustees' remuneration and expenses
During the year, no trustees received any remuneration or other benefits (2023 - £NIL).
During the year ended 31 March 2024, no trustee expenses have been incurred (2023 - £NIL).
9. Debtors
| 2024 | 2023 | |
|---|---|---|
| £ | £ | |
| Prepayments and Tax Recoverable | 2,290 | 3,142 |
Page 11
Docusign Envelope ID: F9E44E73-CEF3-47C7-A82E-D62F3AE837A6
CURE CANCER @ UCL CANCER INSTITUTE
NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 MARCH 2024
10. Creditors: amounts falling due within one year
| 2024 | 2023 | |
|---|---|---|
| £ | £ | |
| Accruals and deferred income | 1,460 | 882 |
Accruals and deferred income balance above includes £500 sponsorship income received towards the annual Clairvoyant event that took place after the year end.
11. Financial instruments
| 2024 | 2023 | |
|---|---|---|
| £ | £ | |
| Financial assets | ||
| Financial assets measured at fair value through income and expenditure | 87,519 | 65,841 |
Financial assets measured at fair value through income and expenditure comprise cash at bank.
Page 12
Docusign Envelope ID: F9E44E73-CEF3-47C7-A82E-D62F3AE837A6
CURE CANCER @ UCL CANCER INSTITUTE
NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 MARCH 2024
12. Statement of funds
Statement of funds - current year
| Unrestricted fund General fund Restricted funds Annual Clairvoyant Evening Total of funds Statement of funds - prior year Unrestricted fund General fund |
Balance at 1 April 2023 £ 68,101 - 68,101 Balance at 1 April 2022 £ 25,565 |
Income £ 25,830 1,000 26,830 Income £ 50,941 |
Expenditure £ (5,582) (1,000) (6,582) Expenditure £ (8,405) |
Balance at 31 March 2024 £ 88,349 |
|---|---|---|---|---|
| - | ||||
| 88,349 | ||||
| Balance at 31 March 2023 £ 68,101 |
A statement of the restricted fund is as follows:
Annual Clairvoyant Evening - Represents a unique event with chairty and the spirit world walking hand in hand together, as always, bringing messages of comfort and healing.
Page 13
Docusign Envelope ID: F9E44E73-CEF3-47C7-A82E-D62F3AE837A6
CURE CANCER @ UCL CANCER INSTITUTE
NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 MARCH 2024
13. Analysis of net assets between funds
Analysis of net assets between funds - current period
| Current assets Creditors: amounts due within one year Total |
Restricted funds 2024 Unrestricted fund 2024 £ £ 500 89,309 (500) (960) - 88,349 |
Total funds 2024 £ 89,809 (1,460) 88,349 |
|---|---|---|
Analysis of net assets between funds - prior period
| Current assets Creditors: amounts due within one year Total |
Unrestricted fund 2023 £ 68,983 (882) 68,101 |
Total funds 2023 £ 68,983 (882) 68,101 |
|---|---|---|
14. Judgements in applying accounting policies and key sources of estimation uncertainty
In the application of the charity's accounting policies the trustees are required to make judgements, estimates and assumptions about the carrying amount of assets and liabilities that are not readily apparent from other sources. The estimates and associated assumptions are based on historical experience and other factors that are considered to be relevant. Actual results may differ from these estimates.
The estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to accounting estimates are recognised in the period in which the estimate is revised, if the revision affects only that period, or in the period of the revision and future periods if the revision affects both current and future periods. However, there are no judgements or assumptions that have a significant risk of causing material adjustment.
Page 14